Drug ID: | NPD5698 |
Drug Name: | |
Molecular Formula: | C23H30O6S |
Canonical SMILES: | CCOc1ccc(cc1)Cc1cc(c(cc1C)OC)[C@@H]1S[C@H](CO)[C@H]([C@@H]([C@H]1O)O)O |
Standard InCHI: | InChI=1S/C23H30O6S/c1-4-29-16-7-5-14(6-8-16)10-15-11-17(18(28-3)9-13(15)2)23-22(27)21(26)20(25)19(12-24)30-23/h5-9,11,19-27H,4,10,12H2,1-3H3/t19-,20-,21+,22-,23+/m1/s1 |
Standard InCHIKey: | WHSOLWOTCHFFBK-ZQGJOIPISA-N |
Max Developmental Stage: | Clinical (unspecified phase) |
Max Developmental Stage Source: | TTD |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient
Tanimoto coefficient is calculated based on PubChem 881-bit substructure fingerprints.
High Similarity Level: Tc>=0.85; Intermediate Similarity Level: 0.7 <= Tc < 0.85; Remote Similarity Level: 0.65 <= Tc < 0.7
TTD | DNCL003772 |
DrugBank | |
ChEMBL | |
IUPHAR/BPS | |
PharmaGKB | |
KEGG Drug | |
PubChem CID | 11988953 |
ChEBI | |
CAS Number |
Molecular Weight | 434.18 |
ALogP | -0.246 |
MLogP | 3.22 |
XLogP | 4.369 |
HDA | 4 |
HBD | 4 |
Rotatable Bonds | 14 |
TPSA | 124.68 |
RO5 Violation | 0 |